Stay updated on Imatinib in Recurrent Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imatinib in Recurrent Psoriasis Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s displayed site revision/version updated from **v3.5.2** to **v3.5.3**, indicating a platform release change rather than a modification to the study record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:43:27.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No additional content changes are indicated.
    Difference
    0.1%
    Check dated 2026-04-18T13:41:00.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-28T01:42:24.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added. The previous entry v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-06T19:02:57.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 instead of Revision: v3.4.1, indicating a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:25:52.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-05T14:17:47.000Z thumbnail image

Stay in the know with updates to Imatinib in Recurrent Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.